4 funding opportunities found in this category. 

Call for Applications: Scleroderma Foundation Established Investigator Grant
Scleroderma Foundation
All Regions
09/15/2012
$150,000

Call for Applications: Scleroderma Foundation Established Investigator Grant

Grant Application Deadline: Sept. 15th annually by 5 p.m. EST

If the 15th falls on a Sat. or Sun., then the following Monday at 5 p.m. EST will be the deadline.

Purpose: The Scleroderma Foundation is seeking applications from promising established investigators both inside and outside the field of SSc research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to SSc. This grant will support pilot research that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources.

Eligibility Requirements: Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals and laboratories. Foreign organizations and institutions are eligible. Applicants must have a doctorate degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences, must have completed a postdoctoral fellowship, have been Principal Investigator on grants from the Scleroderma Foundation or other national, private or government agencies in the past.

Investigators who have questions about eligibility should contact the Scleroderma Foundation (see below).

Mechanism of Support: Applicants may request up to $75,000 (Up to 8% of the Direct Costs per year of award may be set aside as indirect costs. The indirect cost amount will be subtracted from the yearly total [up to $75,000) of the award) per year for up to two years (total for 2 years not to exceed $150,000). These awards are not renewable. Before completion of this grant, investigators are encouraged to seek more substantial continuing support for research through other grant mechanisms through private or government agencies. Replacement of the Principal Investigator on this award is not permitted. There will be no routine escalation for future years.

Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications meeting the stated eligibility requirements.

Research Objectives: The Scleroderma Foundation Innovative Grant is designed to facilitate highly innovative or highly relevant and meritorious pilot projects by established investigators in areas of research related to SSc that will culminate in more substantial funding from Federal or non-federal granting agencies such as the National Institutes of Health, National Science Foundation and the Department of Defense or Veterans Affairs.

Appropriate research areas may include but are not limited to the following as they relate to scleroderma:

Vascular manifestations.
Studies of animal models.
Therapeutic modalities.
Mechanisms of end organ damage.
Immunologic studies.
Endothelial cell biology.
Fibroblast biology.
Models and markers of gender and genetic factors.
Cell signaling.
Epidemiology studies.
Matrix biology.
Stem cell biology.
Health services research (e.g. quality of life, health care delivery.)
Study of clinical manifestation.

Scleroderma Foundation
300 Rosewood Drive, Suite 105
Danvers, MA 01923

Phone: (978) 463-5843 (8:30 a.m. to 5 p.m. ET, Monday through Friday)
Fax: (978) 463-5809
Toll-free: (800) 722-HOPE (4673)

Established Investigator, Physician Researcher
Call for Applications: Scleroderma Foundation New Investigator Grant
Scleroderma Foundation
All Regions
09/15/2012
$150,000

Call for Applications: Scleroderma Foundation New Investigator Grant

Grant Application Deadline: Sept. 15th annually by 5 p.m. EST

If the 15th falls on a Sat. or Sun., then the following Monday at 5 p.m. EST will be the deadline.

Purpose: The Scleroderma Foundation is seeking applications from promising new investigators who hold faculty or equivalent positions and who wish to pursue a career in research related to systemic sclerosis (SSc, scleroderma). This grant will support promising research that is likely to lead to individual research project grants.

Eligibility Requirements: Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals and laboratories. Foreign organizations and institutions are not eligible. These new investigator grants may not be used to support thesis or dissertation research or fellowship training. Applicants must have a doctoral degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences and must have completed a postdoctoral fellowship by the grant award date. Applicants who have been a Principal Investigator on grants from the Scleroderma Foundation or other national, private or government agencies other than fellowship grants are not eligible for this award.

Investigators who have questions about eligibility should contact the Scleroderma Foundation (see below).

Mechanism of Support: Applicants may request up to $50,000 (Up to 8% of the Direct Costs per year of award may be set aside as indirect costs. The indirect costs will be subtracted from the yearly total (up to $50,000) of the award.) per year for up to three years (total for three years not to exceed $150,000). These awards are not renewable. Before completion of this grant, investigators are encouraged to seek continuing support for research through other grant mechanisms through private or government agencies. Replacement of the Principal Investigator on this award is not permitted. There will be no routine escalation for future years.

Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications meeting the stated eligibility requirements.

Research Objectives: The Scleroderma Foundation New Investigator Grant is designed to facilitate the entry of promising new investigators into areas of research related to SSc.

Appropriate research areas may include but are not limited to the following as they relate to scleroderma:

Vascular manifestations.
Studies of animal models.
Therapeutic modalities.
Mechanisms of end organ damage.
Immunologic studies.
Endothelial cell biology.
Fibroblast biology.
Models and markers of gender and genetic factors.
Cell signaling.
Epidemiology studies.
Matrix biology.
Stem cell biology.
Health services research (e.g. quality of life, health care delivery.)
Study of clinical manifestation.

Scleroderma Foundation
300 Rosewood Drive, Suite 105
Danvers, MA 01923

Phone: (978) 463-5843 (8:30 a.m. to 5 p.m. ET, Monday through Friday)
Fax: (978) 463-5809
Toll-free: (800) 722-HOPE (4673)

Junior Investigator, Junior Researcher, Junior Scientist, New Investigator, New Researcher, Young Investigator, Young Scientist
Travel Grant for the Royan International Twin Congress
Royan International Twin Congress
All Regions
05/31/2012
Inquire with funder

Travel Grant for the Royan International Twin Congress

The 8th International Congress on Stem Cell Biology and Technology will be held in in Tehran, Iran in conjunction with the 13th Congress on Reproductive Biomedicine (Royan International Twin Congresses), September 5-7, 2012.

Royan International Twin Congress offers a limited number of travel grants especially young scientists to support a portion of their travel expenses. The grants aim to stimulate the attendance of selected young researchers and practitioners who would have difficulties attending Royan International Twin Congress without this assistance.

If you are interested in a travel grant, please fill in the "Travel Grant Application Form" and email it with a full new version of your CV under the name of “Travel Grant Application” to congress secretariat via : info@royancongress.com

If your abstract is accepted for oral presentation in the congress, please also mention the title of your abstract and your submission code in your application email.

Deadline for all grant application is May 31, 2012. Applications will be evaluated after deadline and you will be informed of the results in June.

Geneticist , Physician Researcher, Biologist, Cell Biologist, Molecular Biologist
Trish Greene International Cancer Nursing Training Workshops
International Union Against Cancer (UICC)
All Regions
12/31/2012
$15,000

Trish Greene International Cancer Nursing Training Workshops

Target candidates Qualified nurses in resource-constrained countries
Duration 3-5 days
Available 5-15 per year

Value A maximum of US $15,000 for travel and stipend for 3 international faculty members
Application closing date None. Applications are accepted at any time
Notification of results Generally within 60 days of registration

Objectives

* Qualified nurses in resource-constrained countries.
* Facilitate a 3 to 5 day teaching and training workshop by an international faculty of up to 3 experts for groups of qualified nurses.
* Provide an opportunity for qualified nurses to augment their professional knowledge and to experience cancer nursing skills as practiced in the receiving host organisation.

Profile of host coordinator

* Appropriately qualified head of department (or similar position) of the organisation applying for and hosting the training workshop

Profile of visiting faculty

* Appropriately qualified and experienced cancer expert(s)

UICC assistance Should you be in need of advice on subject matter and running of a workshop with potentially the necessary international faculty members we may be able to provided assistance. We have expertise in the following domains but workshops do not need to be limited to these fields only:

* Biotherapy, Bone Marrow/Stem Cell Transplant, Chemotherapy, Cultural issues/Cultural diversity, Financial/Cost containment, Healthcare delivery, Oncologic Emergencies, Quality of life, Radiation Oncology, Staffing/Management, Surgical Oncology, Survivorship

Please contact fellows@uicc.org with your requests for assistance.

Note: CNTW applications are accepted in English, French, or Spanish. A special application procedure by the receiving host organization applies

Funding: Trish Greene cancer nursing training workshops are supported by an educational grant from the Oncology Nursing Society and the Oncology Nursing Foundation.

Nurse, Nurse Manager, Oncology Nurse